Details of the Drug Formulations

General Information of Drug (ID: DMS1GYT)

Drug Name
Mirabegron Drug Info
Synonyms Myrbetriq (TN)
Indication
Disease Entry ICD 11 Status REF
Overactive bladder GC50.0 Approved [1]
Cross-matching ID
PubChem CID
9865528
ChEBI ID
CHEBI:65349
CAS Number
223673-61-8
TTD ID
D0X5UN
VARIDT ID
DR00699
INTEDE ID
DR1097
ACDINA ID
D01254

Full List of Drug Formulations Containing This Drug

Mirabegron 8mg/ml extended release for suspension
Company Formulation ID FDA Description
Apgdi F23820 Acesulfame Potassium; Diluted Hydrochloric Acid; Ethylparaben; Hypromellose; Magnesium Stearate; Mannitol; Methylparaben; Silicon Dioxide; Simethicone; Sodium Polystyrene Sulfonate; Xanthan Gum
------------------------------------------------------------------------------------
Mirabegron 25mg extended release tablet
Company Formulation ID FDA Description
Apgdi F23822 Butylated Hydroxytoluene; Hydroxypropyl Cellulose; Hypromellose; Magnesium Stearate; Polyethylene Glycol; Polyethylene Oxide; Yellow Ferric Oxide; Red Ferric Oxide
------------------------------------------------------------------------------------
Mirabegron 50mg extended release tablet
Company Formulation ID FDA Description
Apgdi F23821 Butylated Hydroxytoluene; Hydroxypropyl Cellulose; Hypromellose; Magnesium Stearate; Polyethylene Glycol; Polyethylene Oxide; Yellow Ferric Oxide
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7445).